Mycoplasma pneumoniae: Current knowledge on macrolide resistance and treatment

Frontiers in Microbiology

Volumn 7, Issue JUN, 2016, Pages

  Pereyre, Sabine ^a,b,c   Goret, Julien ^a,b,c   Bébéar, Cécile ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Univ Victor Segalen Bordeaux 2   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Macrolides; Molecular detection; Mycoplasma pneumoniae; Resistance; Treatment

Indexed keywords

AZITHROMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; LEFAMULIN; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; PLEUROMUTILIN ANTIBIOTIC AGENT; POLYMYXIN; PRISTINAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SOLITHROMYCIN; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE; TOSUFLOXACIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; DNA REPAIR; GENE MUTATION; HUMAN; KNOWLEDGE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PNEUMONIA; PRESCRIPTION; PREVALENCE; RESPIRATORY TRACT INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT SURVEY;

EID: 84980409634     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00974     Document Type: Short Survey

References (93)

1. Akaike, H., Miyashita, N., Kubo, M., Kawai, Y., Tanaka, T., Ogita, S., et al. (2012). In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study. Jpn. J. Infect. Dis. 65, 535-538. doi: 10.7883/yoken.65.535
2. Atkinson, T. P., Balish, M. F., and Waites, K. B. (2008). Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol. Rev. 32, 956-973. doi: 10.1111/j.1574-6976.2008.00129.x
3. Atkinson, T. P., Boppana, S., Theos, A., Clements, L. S., Xiao, L., and Waites, K. (2011). Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia. Pediatrics 127, e1605-e1609. doi: 10.1542/peds.2010-2624
4. Averbuch, D., Hidalgo-Grass, C., Moses, A. E., Engelhard, D., and Nir-Paz, R. (2011). Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerging Infect. Dis. 17, 1079-1082. doi: 10.3201/eid/1706.101558
5. Bebear, C. (2012). Editorial commentary: infections due to macrolide-resistant Mycoplasma pneumoniae: now what? Clin. Infect. Dis. 55, 1650-1651. doi: 10.1093/cid/cis791
6. Bébéar, C. M., and Kempf, I. (2005). "Antimicrobial therapy and antimicrobial resistance, "in Mycoplasmas Molecular Biology Pathogenicity and Strategies for Control, eds A. Blanchard and G. F. Browning (Norfolk, VA: Horizon bioscience), 535-568.
7. Bébéar, C. M., and Pereyre, S. (2005). Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr. Drug Targets Infect. Disord. 5, 263-271. doi: 10.2174/1568005054880109
8. Bébéar, C., Pereyre, S., and Peuchant, O. (2011). Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 6, 423-431. doi: 10.2217/fmb.11.18
9. Benitez, A. J., Diaz, M. H., Wolff, B. J., Pimentel, G., Njenga, M. K., Estevez, A., et al. (2012). Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study. J. Clin. Microbiol. 50, 3620-3626. doi: 10.1128/JCM.01755-12
10. Bissessor, M., Tabrizi, S. N., Twin, J., Abdo, H., Fairley, C. K., Chen, M. Y., et al. (2015). Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort, and response of azithromycin failures to alternative antibiotic regimens. Clin. Infect. Dis. 60, 1228-1236. doi: 10.1093/cid/ciu1162
11. Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., et al. (2011). The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin. Infect. Dis. 53, e25-e76. doi: 10.1093/cid/cir531
12. Brown, R. J., Macfarlane-Smith, L., Phillips, S., and Chalker, V. J. (2015). Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015. Euro. Surveill. 20:30078. doi: 10.2807/1560-7917.ES.2015.20.48.30078
13. Cao, B., Zhao, C. J., Yin, Y. D., Zhao, F., Song, S. F., Bai, L., et al. (2010). High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin. Infect. Dis. 51, 189-194. doi: 10.1086/653535
14. Cardinale, F., Chironna, M., Chinellato, I., Principi, N., and Esposito, S. (2013). Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children. J. Clin. Microbiol. 51, 723-724. doi: 10.1128/JCM.02840-12
15. Cardinale, F., Chironna, M., Dumke, R., Binetti, A., Daleno, C., Sallustio, A., et al. (2011). Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia. Eur. Respir. J. 37, 1522-1524. doi: 10.1183/09031936.00172510
16. Chalker, V. J., Pereyre, S., Dumke, R., Winchell, J., Khosla, P., Sun, H., et al. (2015). International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. New Microb. New Infect. 7, 37-40. doi: 10.1016/j.nmni.2015.05.005
17. Chalker, V., Stocki, T., Litt, D., Bermingham, A., Watson, J., Fleming, D., et al. (2012). Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro. Surveill. 17:20081.
18. Chalker, V., Stocki, T., Mentasti, M., Fleming, D., and Harrison, T. (2011). Increased incidence of Mycoplasma pneumoniae infection in England and Wales in 2010: multilocus variable number tandem repeat analysis typing and macrolide susceptibility. Euro Surveill. 16:19865.
19. Chironna, M., Sallustio, A., Esposito, S., Perulli, M., Chinellato, I., Di Bari, C., et al. (2011). Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J. Antimicrob. Chemother. 66, 734-737. doi: 10.1093/jac/dkr003
20. Couldwell, D. L., Tagg, K. A., Jeoffreys, N. J., and Gilbert, G. L. (2013). Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int. J. STD AIDS. 24, 822-828. doi: 10.1177/0956462413502008
21. Critchley, I. A., Jones, M. E., Heinze, P. D., Hubbard, D., Engler, H. D., Evangelista, A. T., et al. (2002). In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe. Clin. Microbiol. Infect. 8, 214-221. doi: 10.1046/j.1469-0691.2002.00392.x
22. Dégrange, S., Cazanave, C., Charron, A., Renaudin, H., Bébéar, C., and Bébéar, C. M. (2009). Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J. Clin. Microbiol. 47, 914-923. doi: 10.1128/JCM.01935-08
23. Degrange, S., Renaudin, H., Charron, A., Pereyre, S., Bébéar, C., and Bébéar, C. M. (2008). Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae. J. Antimicrob. Chemother. 61, 1390-1392. doi: 10.1093/jac/dkn118
24. Diaz, M. H., Benitez, A. J., Cross, K. E., Hicks, L. A., Kutty, P., Bramley, A. M., et al. (2015a). Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect. Dis. 2:ofv106. doi: 10.1093/ofid/ofv106
25. Diaz, M. H., Benitez, A. J., and Winchell, J. M. (2015b). Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J. Clin. Microbiol. 53, 124-130. doi: 10.1128/JCM.02597-14
26. Dumke, R., Luck, C., and Jacobs, E. (2013). Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012. Antimicrob. Agents Chemother. 57, 3460. doi: 10.1128/AAC.00706-13
27. Dumke, R., Schnee, C., Pletz, M. W., Rupp, J., Jacobs, E., Sachse, K., et al. (2015). Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012. Emerg. Infect. Dis. 21, 426-434. doi: 10.3201/eid2103.140927
28. Dumke, R., Stolz, S., Jacobs, E., and Juretzek, T. (2014). Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia. Int. J. Infect. Dis. 29, 197-199. doi: 10.1016/j.ijid.2014.07.014
29. Dumke, R., von Baum, H., Luck, P. C., and Jacobs, E. (2010). Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin. Microbiol. Infect. 16, 613-616. doi: 10.1111/j.1469-0691.2009.02968.x
30. Eshaghi, A., Memari, N., Tang, P., Olsha, R., Farrell, D. J., Low, D. E., et al. (2013). Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011. Emerg. Infect. Dis. 19, 1525-1527. doi: 10.3201/eid1909.121466
31. Esposito, S., Tagliabue, C., Bosis, S., and Principi, N. (2011). Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood. Int. J. Antimicrob. Agents. 37, 472-475. doi: 10.1016/j.ijantimicag.2011.01.008
32. Ferguson, G. D., Gadsby, N. J., Henderson, S. S., Hardie, A., Kalima, P., Morris, A. C., et al. (2013). Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK. J. Med. Microbiol. 62, 1876-1882. doi: 10.1099/jmm.0.066191-0
33. Godron, A., Pereyre, S., Monet, C., Llanas, B., and Harambat, J. (2013). Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection. Pediatr. Nephrol. 28, 2057-2060. doi: 10.1007/s00467-013-2541-5
34. Gruson, D., Pereyre, S., Renaudin, H., Charron, A., Bébéar, C., and Bébéar, C. M. (2005). In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively. Antimicrob. Agents Chemother. 49, 1190-1193. doi: 10.1128/AAC.49.3.1190-1193.2005
35. Hantz, S., Garnier, F., Peuchant, O., Menetrey, C., Charron, A., Ploy, M. C., et al. (2012). Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child. J. Clin. Microbiol. 50, 3402-3405. doi: 10.1128/JCM.01248-12
36. Harris, M., Clark, J., Coote, N., Fletcher, P., Harnden, A., McKean, M., et al. (2011). British Thoracic Society guidelines for the management of community acquired pneumonia in children: update. Thorax. 66 (Suppl. 2), ii1-ii23. doi: 10.1136/thoraxjnl-2011-200598
37. Ho, P. L., Law, P. Y., Chan, B. W., Wong, C. W., To, K. K., Chiu, S. S., et al. (2015). Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J. Clin. Microbiol. 53, 3560-3564. doi: 10.1128/JCM.01983-15
38. Hong, K. B., Choi, E. H., Lee, H. J., Lee, S. Y., Cho, E. Y., Choi, J. H., et al. (2013). Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg. Infect. Dis. 19, 1281-1284. doi: 10.3201/eid1908.121455
39. Ishiguro, N., Koseki, N., Kaiho, M., Kikuta, H., Togashi, T., Oba, K., et al. (2015). Regional differences in prevalence of macrolide-resistant Mycoplasma pneumoniae in Hokkaido, Japan. Jpn. J. Infect. Dis. 69, 186-190. doi: 10.7883/yoken. JJID.2015.054
40. Ji, M., Lee, N. S., Oh, J. M., Jo, J. Y., Choi, E. H., Yoo, S. J., et al. (2014). Single-nucleotide polymorphism PCR for the detection of Mycoplasma pneumoniae and determination of macrolide resistance in respiratory samples. J. Microbiol. Methods. 102, 32-36. doi: 10.1016/j.mimet.2014.04.009
41. Kawai, Y., Miyashita, N., Kubo, M., Akaike, H., Kato, A., Nishizawa, Y., et al. (2013). Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob. Agents Chemother. 57, 4046-4049. doi: 10.1128/AAC.00663-13
42. Kogoj, R., Mrvic, T., Praprotnik, M., and Kese, D. (2015). Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. Euro Surveill. 20:30018. doi: 10.2807/1560-7917.ES.2015.20.37.30018
43. Lin, C., Li, S., Sun, H., Zhao, H., Feng, Y., Cao, L., et al. (2010). Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China. J. Clin. Microbiol. 48, 4567-4572. doi: 10.1128/JCM.00400-10
44. Liu, Y., Ye, X., Zhang, H., Xu, X., Li, W., Zhu, D., et al. (2010). Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn. Microbiol. Infect. Dis. 67, 355-358. doi: 10.1016/j.diagmicrobio.2010.03.004
45. Liu, Y., Ye, X., Zhang, H., Xu, X., and Wang, M. (2012). Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis. J. Clin. Microbiol. 50, 2793-2795. doi: 10.1128/JCM.00678-12
46. Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., et al. (2007). Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44 (Suppl. 2), S27-S72. doi: 10.1086/511159
47. Matsubara, K., Morozumi, M., Okada, T., Matsushima, T., Komiyama, O., Shoji, M., et al. (2009). A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J. Infect. Chemother. 15, 380-383. doi: 10.1007/s10156-009-0715-7
48. Matsuda, K., Narita, M., Sera, N., Maeda, E., Yoshitomi, H., Ohya, H., et al. (2013). Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan. BMC Infect. Dis. 13:591. doi: 10.1186/1471-2334-13-591
49. Matsuoka, M., Narita, M., Okazaki, N., Ohya, H., Yamazaki, T., Ouchi, K., et al. (2004). Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother. 48, 4624-4630. doi: 10.1128/AAC.48.12.4624-4630.2004
50. Meyer Sauteur, P. M., Bleisch, B., Voit, A., Maurer, F. P., Relly, C., Berger, C., et al. (2014). Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland. Swiss Med. Wkly. 144:w14041. doi: 10.4414/smw.2014.14041
51. Meyer Sauteur, P. M., Huber, B. M., and Goetschel, P. (2012). Neuroinvasive Mycoplasma pneumoniae infection without intrathecal antibody response. Pediatr. Infect. Dis. J. 31, 1199-1200. doi: 10.1097/INF.0b013e318266abff
52. Miyashita, N., Akaike, H., Teranishi, H., Ouchi, K., and Okimoto, N. (2013). Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy. Antimicrob. Agents Chemother. 57, 5181-5185. doi: 10.1128/AAC.00737-13
53. Morozumi, M., Iwata, S., Hasegawa, K., Chiba, N., Takayanagi, R., Matsubara, K., et al. (2008). Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob. Agents Chemother. 52, 348-350. doi: 10.1128/AAC.00779-07
54. Morozumi, M., Takahashi, T., and Ubukata, K. (2010). Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother. 16, 78-86. doi: 10.1007/s10156-009-0021-4
55. Niitu, Y., Hasegawa, S., Suetake, T., Kubota, H., Komatsu, S., and Horikawa, M. (1970). Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J. Pediatr. 76, 438-443. doi: 10.1016/S0022-3476(70)80485-1
56. Nilsson, A. C., Bjorkman, P., and Persson, K. (2008). Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 8:93. doi: 10.1186/1471-2180-8-93
57. Okada, T., Morozumi, M., Tajima, T., Hasegawa, M., Sakata, H., Ohnari, S., et al. (2012). Rapid effectiveness of minocycline or doxyxycline against macrolide-resistant Mycoplasma pneumoniae infection in a outbreak among japanese children. Clin. Infect. Dis. 55, 1642-1649. doi: 10.1093/cid/cis784
58. Pereyre, S., Charron, A., Hidalgo-Grass, C., Touati, A., Moses, A. E., Nir-Paz, R., et al. (2012). The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS ONE 7:e38585. doi: 10.1371/journal.pone.0038585
59. Pereyre, S., Charron, A., Renaudin, H., Bébéar, C., and Bébéar, C. M. (2007). First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J. Clin. Microbiol. 45, 3534-3539. doi: 10.1128/JCM.01345-07
60. Pereyre, S., Guyot, C., Renaudin, H., Charron, A., Bébéar, C., and Bébéar, C. M. (2004a). In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 48, 460-465. doi: 10.1128/AAC.48.2.460-465.2004
61. Pereyre, S., Renaudin, H., Bébéar, C., and Bébéar, C. M. (2004b). In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas. Antimicrob. Agents Chemother. 48, 3165-3168. doi: 10.1128/AAC.48.8.3165-3168.2004
62. Pereyre, S., Touati, A., Petitjean-Lecherbonnier, J., Charron, A., Vabret, A., and Bébéar, C. (2013). The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. Clin. Microbiol. Infect. 19, E212-E217. doi: 10.1111/1469-0691.12107
63. Peuchant, O., Menard, A., Renaudin, H., Morozumi, M., Ubukata, K., Bébéar, C. M., et al. (2009). Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J. Antimicrob. Chemother. 64, 52-58. doi: 10.1093/jac/dkp160
64. Pucci, M. J., Podos, S. D., Thanassi, J. A., Leggio, M. J., Bradbury, B. J., and Deshpande, M. (2011). In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens. Antimicrob. Agents Chemother. 55, 2860-2871. doi: 10.1128/AAC.01666-10
65. Rocha, E. P. C., and Blanchard, A. (2002). Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution. Nucleic Acids Res. 30, 2031-2042. doi: 10.1093/nar/30.9.2031
66. Sader, H. S., Paukner, S., Ivezic-Schoenfeld, Z., Biedenbach, D. J., Schmitz, F. J., and Jones, R. N. (2012). Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs). J. Antimicrob. Chemother. 67, 1170-1175. doi: 10.1093/jac/dks001
67. Sakata, H. (2012). Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae. Jpn. J. Antibiot. 65, 173-179.
68. Scapini, J. P., Flynn, L. P., Sciacaluga, S., Morales, L., and Cadario, M. E. (2008). Confirmed Mycoplasma pneumoniae endocarditis. Emerging Infect. Dis. 14, 1664-1665. doi: 10.3201/eid1410.080157
69. Spuesens, E. B., Hoogenboezem, T., Sluijter, M., Hartwig, N. G., van Rossum, A. M., and Vink, C. (2010). Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J. Microbiol. Methods. 82, 214-222. doi: 10.1016/j.mimet.2010.06.004
70. Spuesens, E. B., Meijer, A., Bierschenk, D., Hoogenboezem, T., Donker, G. A., Hartwig, N. G., et al. (2012). Macrolide-resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J. Clin. Microbiol. 50, 1999-2004. doi: 10.1128/JCM.00400-12
71. Stopler, T., and Branski, D. (1986). Resistance of Mycoplasma pneumoniae to macrolides, lincomycin and streptogramin B. J. Antimicrob. Chemother. 18, 359-364. doi: 10.1093/jac/18.3.359
72. Sun, H., Xue, G., Yan, C., Li, S., Cao, L., Yuan, Y., et al. (2013). Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS ONE. 8:e64607. doi: 10.1371/journal.pone.0064607
73. Suzuki, S., Yamazaki, T., Narita, M., Okazaki, N., Suzuki, I., Andoh, T., et al. (2006). Clinical Evaluation of Macrolide-Resistant Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 50, 709-712. doi: 10.1128/AAC.50.2.709-712.2006
74. Uldum, S. A., Bangsborg, J. M., Gahrn-Hansen, B., Ljung, R., Molvadgaard, M., Fons Petersen, R., et al. (2012). Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro. Surveill. 17:20073.
75. Waites, K. B., Bade, D. J., Bébéar, C., Brown, S. D., Davidson, M., Duffy, L. B., et al. (2011). Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas: Approved Guideline. Wayne, PA: Clinical and Laboratory Standards Institute, Document M43-P.
76. Waites, K. B., and Bébéar, C. M. (2013). "Chemotherapy of Mycoplasma and Ureaplasma infections, "in Encyclopedia of Pharmaceutical Microbiology, eds C. Gahan, C. H. Nightingale, and H. Charles (Springer).
77. Waites, K. B., Crabb, D. M., and Duffy, L. B. (2009). Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101. Antimicrob. Agents Chemother. 53, 2139-2141. doi: 10.1128/AAC.00090-09
78. Waites, K. B., Crabb, D. M., Duffy, L. B., and Huband, M. D. (2015). In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas. Antimicrob. Agents Chemother. 59, 3627-3629. doi: 10.1128/AAC.04945-14
79. Wolff, B. J., Thacker, W. L., Schwartz, S. B., and Winchell, J. M. (2008). Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob. Agents Chemother. 52, 3542-3549. doi: 10.1128/AAC.00582-08
80. Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., et al. (2011). Guidelines for the management of adult lower respiratory tract infections-full version. Clin. Microbiol. Infect. 17 (Suppl. 6), E1-E59. doi: 10.1111/j.1469-0691.2011.03672.x
81. Wu, P. S., Chang, L. Y., Lin, H. C., Chi, H., Hsieh, Y. C., Huang, Y. C., et al. (2013). Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan. Pediatr. Pulmonol. 48, 904-911. doi: 10.1002/ppul.22706
82. Xin, D., Mi, Z., Han, X., Qin, L., Li, J., Wei, T., et al. (2009). Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob. Agents Chemother. 53, 2158-2159. doi: 10.1128/AAC.01563-08
83. Xue, G., Wang, Q., Yan, C., Jeoffreys, N., Wang, L., Li, S., et al. (2014). Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China. J. Clin. Microbiol. 52, 1478-1482. doi: 10.1128/JCM.03366-13
84. Yamada, M., Buller, R., Bledsoe, S., and Storch, G. A. (2012). Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr. Infect. Dis. J. 31, 409-410. doi: 10.1097/INF.0b013e318247f3e0
85. Yamazaki, T., Sasaki, T., and Takahata, M. (2007). Activity of garenoxacin against macrolide-susceptible and-resistant Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 51, 2278-2279. doi: 10.1128/AAC.01561-06
86. Yan, C., Sun, H., Lee, S., Selvarangan, R., Qin, X., Tang, Y. W., et al. (2015). Comparison of molecular characteristics of Mycoplasma pneumoniae collected from, U.S. and China. J. Clin. Microbiol. 53, 3891-3893. doi: 10.1128/JCM.02468-15
87. Yan, C., Sun, H., Xue, G., Zhao, H., Wang, L., Feng, Y., et al. (2014). A single-tube multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens by use of multiplex PCR-capillary electrophoresis. J. Clin. Microbiol. 52, 4168-4171. doi: 10.1128/JCM.02178-14
88. Zhao, F., Cao, B., Li, J., Song, S., Tao, X., Yin, Y., et al. (2011). Sequence analysis of the P1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009. J. Clin. Microbiol. 49, 3000-3003. doi: 10.1128/JCM.00105-11
89. Zhao, F., Liu, G., Cao, B., Wu, J., Gu, Y., He, L., et al. (2013a). Multiple-locus variable-number tandem-repeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011. J. Clin. Microbiol. 51, 636-639. doi: 10.1128/JCM.02567-12
90. Zhao, F., Liu, G., Wu, J., Cao, B., Tao, X., He, L., et al. (2013b). Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob. Agents Chemother. 57, 1521-1523. doi: 10.1128/AAC.02060-12
91. Zheng, X., Lee, S., Selvarangan, R., Qin, X., Tang, Y. W., Stiles, J., et al. (2015). Macrolide-resistant Mycoplasma pneumoniae, United States. Emerg. Infect. Dis. 21, 1470-1472. doi: 10.3201/eid2108.150273
92. Zhou, Y., Zhang, Y., Sheng, Y., Zhang, L., Shen, Z., and Chen, Z. (2014). More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob. Agents Chemother. 58, 1034-1038. doi: 10.1128/AAC.01806-13
93. Zhou, Z., Li, X., Chen, X., Luo, F., Pan, C., Zheng, X., et al. (2015). Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China. Antimicrob. Agents Chemother. 59, 1048-1051. doi: 10.1128/AAC.04308-14